EssilorLuxottica S.A. stock (FR0000033219): Strong Q1 growth and valuation debate continue to shape investor interest
08.05.2026 - 13:57:06 | ad-hoc-news.deEssilorLuxottica S.A. has reported a strong first quarter, with revenue growth of 10.8% at constant exchange rates, driven by wearables and core ophthalmic products, according to Morningstar as of May 2026.
Over the past 12 months, the company generated about 28.49 billion euros in revenue and 2.31 billion euros in net profit, with earnings per share of 5.04 euros, according to TipRanks as of May 2026.
As of: 08.05.2026
By the editorial team – specialized in equity coverage.
At a glance
- Name: EssilorLuxottica S.A.
- Sector/industry: Healthcare / Medical Instruments & Supplies
- Headquarters/country: France
- Core markets: Global eyewear and ophthalmic lenses
- Key revenue drivers: Ophthalmic lenses, frames, sunglasses, wearables
- Home exchange/listing venue: Euronext Paris (ticker: EL)
- Trading currency: Euro
EssilorLuxottica S.A.: core business model
EssilorLuxottica S.A. designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses worldwide, operating through multiple business segments that cover lenses, frames, and retail networks.
The company combines lens manufacturing with a large retail footprint, including brands such as Ray?Ban, Oakley, and a network of optical retail stores, which allows it to capture value across the supply chain from production to end?consumer sales.
This vertically integrated model supports pricing power and brand loyalty, particularly in premium sunglasses and high?end optical products, which are key growth areas for the group.
Main revenue and product drivers for EssilorLuxottica S.A.
Wearables and premium sunglasses have been major contributors to recent revenue growth, accounting for roughly half of the 10.8% constant?currency increase in the first quarter, according to Morningstar as of May 2026.
Ophthalmic lenses remain a stable base business, benefiting from aging populations and rising demand for vision correction, while the company’s retail channels provide recurring revenue through lens replacements and frame upgrades.
Analysts at Morningstar note that EssilorLuxottica trades at a price?to?earnings ratio around 36–37, with a trailing dividend yield of about 1.5%, reflecting a mix of growth expectations and income appeal.
Read more
Additional news and developments on the stock can be explored via the linked overview pages.
Conclusion
EssilorLuxottica S.A. continues to grow revenue and earnings, supported by wearables and premium eyewear, but its valuation appears stretched relative to historical norms, according to several research platforms.
For US investors, the stock offers exposure to global eyewear demand and a diversified retail?lens business, though currency risk and competition in the sunglasses segment remain important considerations.
Investors should weigh the company’s strong brand portfolio and integrated model against its elevated multiples and sector?specific risks before making any decisions.
Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.
Media_Description: EssilorLuxottica S.A. logo and eyewear products
Tags: EssilorLuxottica, eyewear, healthcare
ISIN: FR0000033219
Summary:
EssilorLuxottica S.A. reports strong first?quarter revenue growth of 10.8% at constant exchange rates, driven by wearables and core ophthalmic products.
Over the past 12 months, the company generated about 28.49 billion euros in revenue and 2.31 billion euros in net profit, with earnings per share of 5.04 euros.
Analysts debate whether the stock is fairly valued or overpriced, given its price?to?earnings ratio around 36–37 and a trailing dividend yield of about 1.5%.
Text:
EssilorLuxottica S.A. has reported a strong first quarter, with revenue growth of 10.8% at constant exchange rates, driven by wearables and core ophthalmic products, according to Morningstar as of May 2026.
Over the past 12 months, the company generated about 28.49 billion euros in revenue and 2.31 billion euros in net profit, with earnings per share of 5.04 euros, according to TipRanks as of May 2026.
As of: 08.05.2026
By the editorial team – specialized in equity coverage.
At a glance
- Name: EssilorLuxottica S.A.
- Sector/industry: Healthcare / Medical Instruments & Supplies
- Headquarters/country: France
- Core markets: Global eyewear and ophthalmic lenses
- Key revenue drivers: Ophthalmic lenses, frames, sunglasses, wearables
- Home exchange/listing venue: Euronext Paris (ticker: EL)
- Trading currency: Euro
EssilorLuxottica S.A.: core business model
EssilorLuxottica S.A. designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses worldwide, operating through multiple business segments that cover lenses, frames, and retail networks.
The company combines lens manufacturing with a large retail footprint, including brands such as Ray?Ban, Oakley, and a network of optical retail stores, which allows it to capture value across the supply chain from production to end?consumer sales.
This vertically integrated model supports pricing power and brand loyalty, particularly in premium sunglasses and high?end optical products, which are key growth areas for the group.
Main revenue and product drivers for EssilorLuxottica S.A.
Wearables and premium sunglasses have been major contributors to recent revenue growth, accounting for roughly half of the 10.8% constant?currency increase in the first quarter, according to Morningstar as of May 2026.
Ophthalmic lenses remain a stable base business, benefiting from aging populations and rising demand for vision correction, while the company’s retail channels provide recurring revenue through lens replacements and frame upgrades.
Analysts at Morningstar note that EssilorLuxottica trades at a price?to?earnings ratio around 36–37, with a trailing dividend yield of about 1.5%, reflecting a mix of growth expectations and income appeal.
Read more
Additional news and developments on the stock can be explored via the linked overview pages.
Conclusion
EssilorLuxottica S.A. continues to grow revenue and earnings, supported by wearables and premium eyewear, but its valuation appears stretched relative to historical norms, according to several research platforms.
For US investors, the stock offers exposure to global eyewear demand and a diversified retail?lens business, though currency risk and competition in the sunglasses segment remain important considerations.
Investors should weigh the company’s strong brand portfolio and integrated model against its elevated multiples and sector?specific risks before making any decisions.
Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.
So schätzen die Börsenprofis EssilorLuxottica Aktien ein!
FĂĽr. Immer. Kostenlos.
